Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probuphine implants in opioid dependence
NCT02180659Phase 3Completed
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules, Device-based Delivery
01
Overview
A Phase 3 trial of buprenorphine implant in opioid use disorder (OUD), sponsored by Titan Pharmaceuticals, Inc.. Started Jul 2014; status: completed.
02
Drugs
buprenorphine implant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02180659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180659.